Clinical Trial Update: A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating two different doses of lopinavir/ritonavir in HIV-infected patients who have previously taken protease inhibitors and N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: Abbott | Conditions: HIV Infections | Phase 3 | Status: COMPLETED